In contrast, SGLT2 inhibitors decreased cytosolic sodium and protons indirectly by activating the sodium-proton exchanger and sodium-potassium ATPase in diabetes experimental models [44–46]. The gene discussed is SLC5A2; the disease is diabetes mellitus.